American Well Stock

americanwell.comHealthcare / Digital HealthFounded: 2006Funding to Date: $674MM

Amwell (previously known as American Well) is the developer of a telehealth platform connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to American Well before its IPO, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value

Powered by Forge Data

Access valuation and stock price for companies like American Well before its IPO.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About American Well’s Stock

Can you buy American Well’s stock?
You can no longer buy American Well’s stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
Can you sell American Well’s stock?
You can no longer sell stock of American Well on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
What is American Well’s stock price?
The stock price of American Well is $1.07 as of 1/18/24.
What is American Well’s stock ticker symbol?
The ticker symbol of American Well is AMWL.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

American Well investors also invested in these private companies

Teva Pharmaceutical Industries


Management Team

Roy Schoenberg MD
Co-Founder, Board Member, President & Co-CEO
Ido Schoenberg MD
Co-Founder, Chairman & Co-CEO
Peter Antall MD
Chief Medical Officer

Board Members

Brendan O'Grady
Teva Pharmaceutical Industries
Deval Patrick JD
Douglas Wenners JD
Peter Slavin MD


Google-Backed American Well Stock Rises 28% in Market Debut
The strong performance comes after the telehealth company increased the size of its IPO late Wednesday and priced its deal above its anticipated range.
American Well is looking to raise $488.5 million as it goes public. We pored over the 196-page filing to find 5 crucial details about the telehealth giant's plans to change how you get healthcare.
American Well is filing to go public with a $100 million investment from Google. Here are the 5 things you need to know about the companies' plans.
Amwell Files for IPO, Enters Partnership With Google Cloud
American Well Corp., also known as Amwell, filed for an initial public offering with the U.S. Securities and Exchange Commission on Monday, and also entered into a multiyear, strategic partnership with Google Cloud "to deliver transformative telehealth solutions across the global healthcare ecosystem."
Updated on: Jun 14, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.